Sodium oxybate in treatment-resistant rapid-eye-movement sleep behavior disorder

Abstract Study Objectives Symptomatic therapies for rapid-eye-movement (REM) sleep behavior disorder (RBD) are limited. Sodium oxybate (SXB), a gamma-aminobutyric acid (GABA)-B agonist, could be effective but has not been evaluated against placebo. Methods This double-blind, parallel-group, randomiz...

Full description

Bibliographic Details

Published in:	Sleep (New York, N.Y.) Vol. 46; no. 8
Main Authors:	During, Emmanuel H, Hernandez, Beatriz, Miglis, Mitchell G, Sum-Ping, Oliver, Hekmat, Anahid, Cahuas, Ana, Ekelmans, Adrian, Yoshino, Fuyumi, Mignot, Emmanuel, Kushida, Clete A
Format:	Journal Article
Language:	English
Published:	US Oxford University Press 14-08-2023
Subjects:	Adult Anxiety Anxiety Disorders Behavior disorders Humans Neurological Disorders REM Sleep Behavior Disorder - complications REM Sleep Behavior Disorder - drug therapy Sleep Sodium Oxybate - therapeutic use parasomnia sodium oxybate Parkinson’s disease REM sleep behavior disorder
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!